{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:47:05Z","timestamp":1791863225851,"version":"4.3.4"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Antipsychotic drugs (AP) are widely prescribed for the treatment of schizophrenia and psychosis. The pharmacological treatment of schizophrenia is often performed with the simultaneous use of two or more antipsychotic agents to achieve the desired control of psychotic symptoms Available AP include both conventional (typical) and new (atypical) antipsychotic medications. Atypical AP, such as quetiapine, now account for the vast majority of AP prescriptions. In forensic toxicology, AP are of considerable interest because of their potential abuse and their involvement in intoxications and suicides. The authors retrospectively examined AP positive cases detected in samples collected during autopsies performed in the Forensic Clinical and Pathology Service of National Institute of Legal Medicine and Forensic Sciences Centre Branch or in other autopsies carried out in the central region of Portugal, between January 2016 and December 2018. A quantitative liquid chromatography\u2013tandem mass spectrometry assay was developed for the simultaneous determination of 16 AP (amisulpride, aripiprazole, chlorpromazine, clozapine, cyamemazine, fluphenazine, haloperidol, levomepromazine, melperone, olanzapine, paliperidone, promethazine, quetiapine, risperidone, sulpiride and ziprasidone) in blood samples of postmortem cases. The Laboratory of Forensic Chemistry and Toxicology received 3,588 requests for toxicological analysis: 1,413 cases were positive for drugs from which 351 (24.8%) cases were positive for AP, 60.1% from male individuals and 39.9% from female. Quetiapine was the most prevalent AP (36.5%) followed by olanzapine (20.8%). During this period, there were 25 postmortem cases with AP blood concentrations above therapeutic range, in which 36% of those are in agreement with the information received (psychological history or acute intoxication suspicion) and the manner of death was suicide. Our results point that antipsychotics are an increasingly prevalent class of drugs. AP must be measured not only in toxic concentrations but also in therapeutic levels in postmortem cases; therefore, it is important to come up with a sensitive method to cover the low therapeutic range in which AP are usually present.<\/jats:p>","DOI":"10.1093\/jat\/bkaa100","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T11:11:04Z","timestamp":1596539464000},"page":"915-922","source":"Crossref","is-referenced-by-count":19,"title":["Identification and Quantification of Antipsychotics in Blood Samples by LC\u2013MS-MS: Case Reports and Data from Three Years of Routine Analysis"],"prefix":"10.1093","volume":"44","author":[{"given":"Paula","family":"Proen\u00e7a","sequence":"first","affiliation":[{"name":"Instituto Nacional de Medicina Legal e Ci\u00eancias Forenses, I.P., Delega\u00e7\u00e3o do Centro, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Medicina Legal e Ci\u00eancias Forenses, I.P., Delega\u00e7\u00e3o do Centro, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Mustra","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Medicina Legal e Ci\u00eancias Forenses, I.P., Delega\u00e7\u00e3o do Centro, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alda","family":"Claro","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Medicina Legal e Ci\u00eancias Forenses, I.P., Delega\u00e7\u00e3o do Centro, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Franco","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Medicina Legal e Ci\u00eancias Forenses, I.P., Delega\u00e7\u00e3o do Sul, Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Corte-Real","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Medicina Legal e Ci\u00eancias Forenses, I.P., Delega\u00e7\u00e3o do Centro, Coimbra, Portugal"},{"name":"Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"2020121209235036300_R1","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1503\/cmaj.1041064","article-title":"Modern antipsychotic drugs: A critical overview","volume":"172","author":"Gardner","year":"2005","journal-title":"Canadian Medical Association journal"},{"key":"2020121209235036300_R2","first-page":"206","volume-title":"Principles of Pharmacology. The Pathophysiologic Basic of Drug Therapy","author":"Standaert","year":"2017","edition":"4th edition"},{"key":"2020121209235036300_R3","first-page":"279","volume-title":"Goodman & Gilman\u2019s the Pharmacological Basis of Therapeutics","author":"Meyer","year":"2018","edition":"13th edition"},{"key":"2020121209235036300_R4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.euroneuro.2013.06.005","article-title":"Schizophrenia and dopamine receptors","volume":"23","author":"Seeman","year":"2013","journal-title":"European Neuropsychopharmacology"},{"key":"2020121209235036300_R5","first-page":"95","volume-title":"History of Psychopharmacology","author":"Meyer","year":"2013"},{"key":"2020121209235036300_R6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.7326\/0003-4819-146-11-200706050-00006","article-title":"Antipsychotic drug use and mortality in older adults with dementia","volume":"146","author":"Gill","year":"2007","journal-title":"Annals of Internal Medicine"},{"key":"2020121209235036300_R7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"The New England Journal of Medicine"},{"key":"2020121209235036300_R8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2478\/acph-2014-0036","article-title":"Therapeutic drug monitoring of atypical antipsychotic drugs","volume":"64","author":"Grundmann","year":"2014","journal-title":"Acta Pharmaceutica"},{"key":"2020121209235036300_R9","first-page":"1","article-title":"The pharmacology and toxicology of atypical antipsychotic agents","volume":"39","author":"Burns","year":"2001","journal-title":"Clinical Toxicology"},{"key":"2020121209235036300_R10","first-page":"1","article-title":"Psicof\u00e1rmacos: Evolu\u00e7\u00e3o do consumo em Portugal Continental (2000\u20132012)","volume-title":"Gabinete de Estudos e Projectos. Infarmed, I.P.","author":"Furtado","year":"2013"},{"key":"2020121209235036300_R11","article-title":"Antipsychotic drug consumption in Portugal: A nationwide trend from 2008 to 2017","author":"Bernardo","year":"2019"},{"key":"2020121209235036300_R12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.forsciint.2016.05.002","article-title":"Antipsychotics\u2014Postmortem fatal and non-fatal reference concentrations","volume":"266","author":"S\u00f6derberg","year":"2016","journal-title":"Forensic Science International"},{"key":"2020121209235036300_R13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules24203636","article-title":"Determination of antidepressants and antipsychotics in dried blood spots (DBSs) collected from post-mortem samples and evaluation of the stability over a three-month period","volume":"24","author":"Moretti","year":"2019","journal-title":"Molecules"},{"key":"2020121209235036300_R14","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/jms.1783","article-title":"Identification and quantification of 30 antipsychotics in blood using LC-MS\/MS","volume":"45","author":"Saar","year":"2010","journal-title":"Journal of Mass Spectrometry"},{"key":"2020121209235036300_R15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jms.440","article-title":"Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography\/mass spectrometry with atmospheric pressure chemical ionization","volume":"38","author":"Kratzch","year":"2003","journal-title":"Journal of Mass Spectrometry"},{"key":"2020121209235036300_R16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/jat\/32.2.147","article-title":"Quantification of seven low-dosage antipsychotic drugs in human postmortem blood using LC-MS\/MS","volume":"32","author":"Roman","year":"2008","journal-title":"Journal of Analytical Toxicology"},{"key":"2020121209235036300_R17","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/chromsci\/bmy024","article-title":"Simultaneous determination of antipsychotic drugs and their active metabolites by LC\u2013MS-MS and its application to therapeutic drug monitoring","volume":"56","author":"Miroshnichenko","year":"2018","journal-title":"Journal of Chromatographic Science"},{"key":"2020121209235036300_R18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.forsciint.2013.02.010","article-title":"LC-MS\/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood","volume":"229","author":"Fisher","year":"2013","journal-title":"Forensic Science International"},{"key":"2020121209235036300_R19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.forsciint.2012.01.002","article-title":"Screening and quantification of antipsycotic drugs in human brain tissue by liquid chromatography-tandem mass spectrometry: Application to post-mortem diagnostic of forensic interest","volume":"219","author":"Sampedro","year":"2012","journal-title":"Forensic Science International"},{"key":"2020121209235036300_R20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/dta.1337","article-title":"The analysis of antipsychotics drugs in human matrices using LC-MS(\/MS)","volume":"4","author":"Saar","year":"2012","journal-title":"Drug Testing and Analysis"},{"key":"2020121209235036300_R21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/bmc.997","article-title":"Bioanalytical methods for the determination of antipsychotics drugs","volume":"22","author":"Zhang","year":"2008","journal-title":"Biomedical Chromatography"},{"key":"2020121209235036300_R22","first-page":"50","article-title":"Structure of chemical compounds, methods of analysis and process control","volume":"50","author":"Baymeeva","year":"2016","journal-title":"Pharmaceutical Chemistry Journal"},{"key":"2020121209235036300_R23","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2018-0155.","article-title":"Schizophrenia: Recent advances in LC\u2013MS\/MS methods to determine antipsychotic drugs in biological samples: A review","author":"Queiroz","year":"2019","journal-title":"Bioanalysis"},{"key":"2020121209235036300_R24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00769-002-0516-5","article-title":"Bioanalytical method validation and its implications for forensic and clinical toxicology - A review","volume":"7","author":"Peters","year":"2002","journal-title":"Accreditation and Quality Assurance"},{"key":"2020121209235036300_R25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.forsciint.2006.05.021","article-title":"Validation of new methods","volume":"165","author":"Peters","year":"2007","journal-title":"Forensic Science International"},{"key":"2020121209235036300_R26","volume-title":"Standard Practices for Method Validation in Forensic Toxicology SWGTOX Doc 003","author":"SWGTOX \u2013 Scientific Working Group for Forensic Toxicology"},{"key":"2020121209235036300_R27","volume-title":"International Standard for Laboratories. Identification criteria for qualitative assays TD2010IDCR","author":"WADA \u2013 World Anti-Doping Agency"},{"key":"2020121209235036300_R28","doi-asserted-by":"publisher","first-page":"pp. 152","DOI":"10.1016\/j.forsciint.2011.02.022","article-title":"Assessment of the stability of 30 antipsychotic drugs in stored blood specimens","volume":"215","author":"Saar","year":"2011","journal-title":"Forensic Science International"},{"key":"2020121209235036300_R29","doi-asserted-by":"publisher","first-page":"pp. 454","DOI":"10.1097\/00007691-200108000-00023","article-title":"Instability of olanzapine in calf serum","volume":"23","author":"Lakso","year":"2001","journal-title":"Therapeutic Drug Monitoring"},{"key":"2020121209235036300_R30","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.jpba.2004.01.005","article-title":"A study of matrix effects on an LC\/MS\/MS assay for olanzapine and desmethyl olanzapine","volume":"35","author":"Chin","year":"2004","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"2020121209235036300_R31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/wps.20128","article-title":"Risks of all-cause and suicide mortality in mental disorders: A meta-review","volume":"13","author":"Chesney","year":"2014","journal-title":"World Psychiatry"},{"key":"2020121209235036300_R32","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20128","article-title":"Suicide risk and mental disorders","volume":"15","author":"Br\u00e5dvik","year":"2018","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"2020121209235036300_R33","volume-title":"Reference blood level list of therapeutic and toxic substances","author":"The International Association of Forensic Toxicologists","year":"2004"},{"key":"2020121209235036300_R34","doi-asserted-by":"publisher","DOI":"10.1186\/cc11441","article-title":"Therapeutic and toxic blood concentrations of nearly 1000 drugs and other xenobiotics","volume":"16","author":"Schulz","year":"2012","journal-title":"Critical Care"},{"key":"2020121209235036300_R35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.forsciint.2006.02.013","article-title":"The redistribution of selected psychiatric drugs in post-mortem cases","volume":"164","author":"Rodda","year":"2006","journal-title":"Forensic Science International"},{"key":"2020121209235036300_R36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/jat\/29.5.407","article-title":"Cases studies of postmortem quetiapine: Therapeutic or toxic concentrations?","volume":"29","author":"Parker","year":"2005","journal-title":"Journal of Analytical Toxicology"},{"key":"2020121209235036300_R37","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/jat\/28.6.520","article-title":"Fatal overdoses associated with quetiapine","volume":"28","author":"Langman","year":"2004","journal-title":"Journal of Analytical Toxicology"},{"key":"2020121209235036300_R38","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/jat\/24.4.300","article-title":"Quetiapine (Seroquel\u00ae) concentrations in seven postmortem cases","volume":"24","author":"Anderson","year":"2000","journal-title":"Journal of Analytical Toxicology"},{"key":"2020121209235036300_R39","first-page":"381","article-title":"Quetiapine-related fatalities","volume":"25","author":"Mainland","year":"2001","journal-title":"Journal of Analytical Toxicology"},{"key":"2020121209235036300_R40","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1080\/10826084.2019.1668013","article-title":"Quetiapine abuse fourteen years later: Where are we now? A systematic review","volume":"55","author":"Vento","year":"2020","journal-title":"Substance Use & Misuse"},{"key":"2020121209235036300_R41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/2279-042X.200987","article-title":"Quetiapine misuse and abuse: Is it an atypical paradigm of drug seeking behavior?","volume":"6","author":"Kim","year":"2017","journal-title":"Journal of Research in Pharmacy Practice"},{"key":"2020121209235036300_R42","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3109\/14659891.2013.810309","article-title":"Quetiapine abuse and dependence in psychiatric patients: A systematic review of 25 case reports in the literature","volume":"19","author":"Cubala","year":"2014","journal-title":"Journal of Substance Use"},{"key":"2020121209235036300_R43","first-page":"13","article-title":"Is Seroquel developing an illicit reputation for misuse\/abuse?","volume":"7","author":"Sansone","year":"2010","journal-title":"Psychiatry (Edgmont)"},{"key":"2020121209235036300_R44","first-page":"253","article-title":"A review of olanzapine-associated toxicity and fatality in overdose","volume":"28","author":"Chue","year":"2003","journal-title":"Journal of Psychiatry and Neuroscience"},{"key":"2020121209235036300_R45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/jat\/33.1.15","article-title":"Postmortem tissue concentrations of olanzapine","volume":"33","author":"Vance","year":"2009","journal-title":"Journal of Analytical Toxicology"},{"key":"2020121209235036300_R46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/00085030.1995.10757476","article-title":"A death involving an overdose of clozapine","volume":"28","author":"Singer","year":"1995","journal-title":"Canadian Society of Forensic Science Journal"},{"key":"2020121209235036300_R47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF01225229","article-title":"Clozapine cases with fatal, toxic or therapeutic concentrations","volume":"106","author":"Worm","year":"1993","journal-title":"International Journal of Legal Medicine"},{"key":"2020121209235036300_R48","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1177\/0004867412438871","article-title":"A review of the use of clozapine levels to guide treatment and determine cause of death","volume":"46","author":"Stark","year":"2012","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"2020121209235036300_R49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0379-0738(03)00260-3","article-title":"Acute fatal poisoning with cyamemazine","volume":"137","author":"Alunni-Perret","year":"2003","journal-title":"Forensic Science International"},{"key":"2020121209235036300_R50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/00085030.2003.10757555","article-title":"Case study: Distribution and redistribution of levomepromazine and its metabolites in a fatal poisoning","volume":"30","author":"Klys","year":"2003","journal-title":"Canadian Society of Forensic Science Journal"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkaa100\/33635120\/bkaa100.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/44\/8\/915\/34880803\/bkaa100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/44\/8\/915\/34880803\/bkaa100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T14:24:21Z","timestamp":1607783061000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/44\/8\/915\/5890365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,11]]},"published-print":{"date-parts":[[2020,12,12]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkaa100","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10,1]]},"published":{"date-parts":[[2020,8,11]]}}}